A Neo-Substrate that Amplifies Catalytic Activity of Parkinson’s-Disease-Related Kinase PINK1
Nicholas T. Hertz(Howard Hughes Medical Institute), Kevan M. Shokat(Howard Hughes Medical Institute), Kurt S. Thorn(University of California, San Francisco), Ken Nakamura(Gladstone Institutes), A. L. Burlingame(University of California, San Francisco), Martin L. Sos(German Cancer Research Center), Amandine Berthet(Institut des Maladies Neurodégénératives)
Cited by 274
Related Papers
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
|Nature|2009|4.2k
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
|Nature|2013|2.5k
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
|Nature|2010|1.8k
IRE1 Signaling Affects Cell Fate During the Unfolded Protein Response
|Science|2007|1.4k